Nuritas

Nuritas is a biotech company that uses data mining of molecules in food and food byproducts to identify supplements and new drugs.

Nuritas mission is to use their unique capabilities to tackle the health challenges facing the world of today as well as the world of tomorrow and, ultimately, improve the lives of billions of people around the globe. 

Nuritas was founded in 2014 by Nora Khaldi. The company is headquartered in Dublin, Dublin, Leinster, Ireland.

 

Nuritas has already developed and patented health-improving ingredients that can address global challenges as broad as inflammation, diabetes, and MRSA. It has also developed PeptAIde, the world’s first bioactive ingredient discovered and delivered through artificial intelligence.

 

Nuritas discovers and delivers new patented and highly innovative ingredients for companies operating across the Medical Food, Functional Food, Supplement and Over-the- Counter treatment areas.

 

Nuritas' peptide portfolio is used by a wide range of partners to enrich their products with natural scientifically proven health benefits. Nuritas has partnered with some of the world’s leading ingredient, food and pharmaceutical corporations to discover natural peptides with health benefits.

 

Nuritas is backed by European Investment Bank (EIB), Cleveland Avenue, Wheatsheaf Group, European Circular Bioeconomy Fund, Vertex Holdings, Nutresa Ventures, Marc Benioff, Cultivian Sandbox Ventures, VisVires New Protein, andd others. The company raised $45M (€39M) in Series B round on Nov 11, 2021. This brings Nuritas' total funding to $109M to date.

  

 

  • Year founded: 2014
  • Funding Info: $109M over 4 Rounds (Last Funding Type: Series B)
  • Yearly Revenue: NA
  • Employee Size: 51-200
  • Business Valuation: NA
  • City/Town: Dublin
  • State: Leinster
  • Country: Ireland
Related businesses